(Q45077756)

English

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

scientific article published in October 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

steatohepatitis

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Sanjay K Satapathy

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sanjay Garg

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ranjeet Chauhan

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Puja Sakhuja

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Veena Malhotra

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Barjesh C Sharma

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Shiv K Sarin

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1946-1952

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Inhibition of endogenous TNF formation by pentoxifylline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Diagnosis of fatty liver disease: is biopsy necessary?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Protection from obesity-induced insulin resistance in mice lacking TNF-α function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

The role of cytokines in cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

TNF-alpha and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Pentoxifylline and wellbeing in cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2004.40220.X

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45077756&oldid=2065292038"